Indication Bioscience Granted First Patent for Statin Plus Cannabidiol (CBD) Combination

"...announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent US10835501B2, which relates to pharmaceutical compositions comprising a statin and a cannabinoid, and their use for the treatment of hypercholesterolemia and atherosclerosis.

020121 Indication Bioscience Granted Fir
.
Download • 54KB

According to the CDC, approximately 28% of Americans over forty years of age are prescribed a statin for hyper

cholesterolemia. Current statin therapies are associated with adverse effects including myalgia. In US clinical practices, roughly 45% of patients discontinue statin use after 6 months use due to adverse effects..."